Old Web
English
Sign In
Acemap
>
Paper
>
270TiPMutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
270TiPMutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer (TNBC)
2017
Katrin Frenzel
L. Heesen
S. Bolte
Valesca Bukur
Mustafa Diken
Evelyna Derhovanessian
Sebastian Kreiter
Andreas Kuhn
Klaus Kuehlcke
Martin Löwer
J.-P. De Greve
Henrik Lindman
Steve Pascolo
Marcus Schmidt
Andreas Schneeweiss
Tobias Sjöblom
Kris Thielemans
Laurence Zitvogel
Ö. Türeci
Ugur Sahin
Keywords:
Medicine
Pathology
RNA
Triple-negative breast cancer
Internal medicine
Oncology
immuno therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]